Pfizer Started as a “Buy” at Jefferies & Co. (PFE)

Comment

Shutterstock photo

Pharma giant Pfizer Inc. ( PFE ) saw its coverage initiated on Friday with a "Buy" rating by analysts at Jefferies & Co.

The firm also set a $17.80 price target on PFE stock, which closed at $15.23 on Thursday. Jefferies cited several promising, late-stage pipeline assets for the positive view.

Pfizer shares were mostly flat in premarket trading Friday.

The Bottom Line
We have been recommending shares of PFE since Dec.10, when the stock was trading at $18.24. The company has a 4.73% dividend yield, based on last night's closing stock price of $15.23.

Pfizer Inc. ( PFE ) is a "recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Created by Dividend.com



This article appears in: Investing , Stocks


More from Dividend.com







Dividend.com
Contributor:

Dividend.com

Dividends
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com